IL188618A0
Hcv ns3 protease inhibitors
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
57 members in 34 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 70076405 | United States of America | P | |
| 72456605 | United States of America | P | |
| 2006027573 | United States of America | W |
Members57
| Document | Office | Kind | |
|---|---|---|---|
| US2007027071A1 | United States of America | A1 | |
| AU2006276189A1 | Australia | A1 | |
| CA2615022A1 | Canada | A1 | |
| WO2007015787A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2007015855A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW200740850A | Taiwan Province of China | A | |
| AR057456A1 | Argentina | A1 | |
| CR9621A | Costa Rica | A | |
| MX2008000866A | Mexico | A | |
| KR20080027860A | Republic of Korea | A | |
| IL188618A0This record | Israel | A0 | |
| EP1910404A1 | European Patent Office (EPO) | A1 | |
| NO20080879L | Norway | L | |
| EP1924593A1 | European Patent Office (EPO) | A1 | |
| EA200800371A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CN101228181A | China | A | |
| US7470664B2 | United States of America | B2 | |
| JP2009502793A | Japan | A | |
| MA30198B1 | Morocco | B1 | |
| HK1121169A1 | Hong Kong, China | A1 | |
| US2009124661A1 | United States of America | A1 | |
| TNSN08033A1 | Tunisia | A1 | |
| EP1924593B1 | European Patent Office (EPO) | B1 | |
| AT443075T | Austria | T | |
| ATE443075T1 | Austria | T1 | |
| DE602006009280D1 | Germany | D1 | |
| EP1924593B8 | European Patent Office (EPO) | B8 | |
| PT1924593E | Portugal | E | |
| DK1924593T3 | Denmark | T3 | |
| HRP20090627T1 | Croatia | T1 | |
| ES2332821T3 | Spain | T3 | |
| PL1924593T3 | Poland | T3 | |
| EA013331B1 | Eurasian Patent Organization (EAPO) | B1 | |
| SI1924593T1 | Slovenia | T1 | |
| EP1924593B9 | European Patent Office (EPO) | B9 | |
| UA90909C2 | Ukraine | C2 | |
| ZA200800072B | South Africa | B | |
| SG164376A1 | Singapore | A1 | |
| NZ565223A | New Zealand | A | |
| RS51101B | Serbia | B | |
| MY142240A | Malaysia | A | |
| BRPI0613633A2 | Brazil | A2 | |
| JP4621282B2 | Japan | B2 | |
| JP2011079828A | Japan | A | |
| GEP20115248B | Georgia | B | |
| AU2006276189B2 | Australia | B2 | |
| AU2006276189B9 | Australia | B9 | |
| US8216999B2 | United States of America | B2 | |
| CA2615022C | Canada | C | |
| TWI387603B | Taiwan Province of China | B | |
| KR101296095B1 | Republic of Korea | B1 | |
| CN101228181B | China | B | |
| JP5345117B2 | Japan | B2 | |
| EP1910404B1 | European Patent Office (EPO) | B1 | |
| ES2446015T3 | Spain | T3 | |
| EP1910404B9 | European Patent Office (EPO) | B9 | |
| ES2446015T9 | Spain | T9 |
Numbers
- Application
- 188618
Titles
- English
- HCV NS3 PROTEASE INHIBITORS
Classification
- CPC, 12
- C07K5/0808
- C07D487/18
- A61K38/00
- C07K5/0812
- C07K5/0827
- A61P1/16
- A61P31/00
- A61P31/12
- A61P31/14
- A61P43/00
- C07D487/22
- A61K31/407